Inaugural Asia Summit on Global Health held 24 November in hybrid format in Hong Kong
HONG KONG, Nov. 23, 2021 /PRNewswire/ -- Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) will take place on 24 November 2021 at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format, offering both online and...
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings
Purchase of Assets and Related Global Commercialization Rights for Oral 9-cis-Retinol (Zuretinol) for Rare Forms of Childhood Blindness. Clinical Stage Asset Has Potential for First Approved Oral Therapy for Leber's Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP) Caused by Mutations of the RPE65 or Lecithin:Retinol Acyltransferase (LRAT) Gene. Program Has Received FDA Rare Pediatric Disease...
HKeyBio Lauched the Most Comprehesive Non-human Primate Autoimmune & Allergic Disease Model Matrix to Redefining Clinical Translation
BOSTON and SUZHOU, China, Sept. 23, 2025 /PRNewswire/ -- HKeyBio, a CRO specializing in preclinical and translational autoimmune-drug development, today announced the launch of HKEY-NHP-MATRIX2.0, a next-generation platform designed to improve the reliability of translating novel autoimmune and allergy therapies from preclinical research to clinical success. Platform Highlights Broad Primate Disease Model LibraryThe platform includes over twenty non-human...
TraceLink Becomes First Solution Provider to Secure All 16 GS1 US Conformance Trustmarks for EPCIS File Support
BOSTON, Aug. 26, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, proudly announces it has become the first and only solution provider to secure all 16 GS1 US Conformance Trustmarks for EPCIS file support. These trustmarks certify that...
China Pharma Announces Receipt of Noncompliance Notice from NYSE American
HAIKOU, China, June 23, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on June 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the "Exchange") stating that the Company was not in compliance with the continued listing standards...
BrightInsight Named 2023 Global Company of the Year by Frost & Sullivan for Enabling Better Patient Outcomes with Digital Solutions
BrightInsight's Platform and out-of-the-box Disease Management Solution speed time to market for patient apps, enabling biopharma to differentiate their therapies, improve conversion and enhance the patient experience. SAN ANTONIO, May 23, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed the healthcare Internet of Things (IoT) solutions industry and based on its findings, recognizes...
Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing
SHANGHAI and YANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, announced the closing of RMB 550 million in Series C financing. Participating investors in this round include a renowned healthcare fund, Yangzhou Guojin Investment Group Co. LTD, and Kingray Capital....
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
Product News: ZEISS announces enhanced visualization capabilities with the new ZEISS ARTEVO 850 3D heads-up ophthalmic microscope. Spatial Computing Innovation: ZEISS will demonstrate a digital application for experiencing 3D videos and more on the Apple Vision Pro. Workflow Innovation: The recently FDA-approved VISUMAX 800 with SMILE pro software will be...
Korea Zinc announces non-renewal of sulfuric acid consignment contract with Young Poong
The consignment of sulfuric acid originated from Young Poong's Seokpo Smelter adds to the operational risks for Korea Zinc Young Poong has passed the costs and risks associated with sulfuric acid management to Korea Zinc while backlash from the local community adds to the burden Additional supply will put...
Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376
SHANG HAI, March 2, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that it has entered into an exclusive Out-License Agreement (the "Agreement" hereafter) with Shanghai Allist Pharmaceuticals Co., Ltd., ("Allist" hereafter) for the further development, manufacture, use, and sales of (EGFR-TKI) ABK3376 in China (Mainland China, Hong...
